Obacz et al. reported that AGR3 positivity was associated with better outcome (progression free survival and overall survival) in the subgroup of patients with tumors characterized by lower histological grade but not by higher histological grade in breast cancer [50]. The gene discussed is AGR3; the disease is breast cancer.